FDA issued a Warning Letter to Neurolumen LLC on 5/30/2014 as a result of this inspection.
483 Neurolumen Dec 2013

483 Neurolumen Dec 2013

Akbar Zaidi FDA$119.00 - Available Now

FDA investigators audited the Neurolumen - Oklahoma City, OK, United States facility and issued 11 inspectional observations (via FDA 483) on 13 Dec 2013.

Product details

  • Category: Medical Devices & Rad Health
  • Number of Observations: 11
  • Inspection end: 13 Dec 2013
  • Location: Oklahoma City, United States
  • FEI: 3010144038
Add To Cart